Dr. Kudchadkar on the FDA Approval of Avelumab in Merkel Cell Carcinoma
0 विचारों
administrator
07/17/23
Ragini Kudchadkar, MD, assistant professor, Department of Hematology and Medical Oncology, associate director, Hematology and Medical Oncology Fellowship Program-Clinical/Service, Emory University School of Medicine, discusses the FDA approval of avelumab for the treatment of patients with Merkel cell carcinoma.
और दिखाओ
फेसबुक टिप्पणियाँ
कोई टिप्पणी नहीं मिली